SKI Market

A+| A| A-|

Indian Indices

Sensex

77,269.40 355.90
( 0.46%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,363.93 -14.87
(-0.14%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Dishman Carbogen Amcis Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

540701

INE385W01011

253.2585939

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DCAL

2878.54

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	399.84	327.35	402.55	306.61	200.32	580.74
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	399.84	327.35	402.55	306.61	200.32	580.74
Other Income	32.98	63.05	52.16	60.39	66.15	69.55
Stock Adjustments	-14.00	-8.27	-8.00	7.70	-22.54	-19.96
Total Income	418.82	382.13	446.71	374.70	243.93	630.33
EXPENDITURE :
Raw Materials	117.01	107.70	163.35	107.11	75.04	180.15
Power & Fuel Cost	32.16	28.71	33.07	24.83	12.78	35.27
Employee Cost	90.15	91.54	86.13	79.04	58.23	88.87
Other Manufacturing Expenses	21.69	27.94	31.21	22.57	18.95	26.56
Selling & Administrative Expenses	50.59	46.30	52.54	46.03	28.90	42.84
Miscellaneous Expenses	2.45	13.14	22.49	2.21	43.20	13.51
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	314.05	315.33	388.79	281.79	237.10	387.20
Operating Profit	104.77	66.80	57.92	92.91	6.83	243.13
Interest	70.40	68.19	57.92	37.23	34.17	47.02
Gross Profit	34.37	-1.39	0.00	55.68	-27.34	196.11
Depreciation	65.20	101.61	96.20	140.07	141.35	140.65
Profit Before Tax	-30.83	-103.00	-96.20	-84.39	-168.69	55.46
Tax	0.00	11.06	0.00	0.00	17.97	9.30
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-20.96	-37.65	-37.33	-52.84	46.15	7.64
Reported Net Profit	-9.87	-76.41	-58.87	-31.55	-232.81	38.52
Extraordinary Items	1.31	-1.02	-2.79	-0.79	2.52	-4.06
Adjusted Net Profit	-11.18	-75.39	-56.08	-30.76	-235.33	42.58
Adjustment below Net Profit	0.49	-0.07	0.33	0.10	-0.51	-0.27
P & L Balance brought forward	-310.93	-234.45	-175.91	-144.47	88.85	53.83
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	3.23
P & L Balance carried down	-320.31	-310.93	-234.45	-175.92	-144.47	88.85
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-0.63	-4.87	-3.75	-2.01	-14.85	2.46
Earnings Per Share(Adj)-Unit Curr	-0.63	-4.87	-3.75	-2.01	-14.85	2.46
Book Value-Unit Curr	257.05	258.46	262.39	269.88	298.13	305.66
Book Value(Adj)-Unit Curr	257.05	258.46	262.39	269.88	298.13	305.66

77,269.40 355.90 ( 0.46%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,363.93 -14.87 (-0.14%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)